Express the truth to gain the trust

Home » Speaker Details




Information about Bartorelli A.
No personal information available


A. Bartorelli's Course Programme
Case 3 conclusion EuroPCR 2009 19-05-2009
Diabetes associated with significant renal failure EuroPCR 2009 19-05-2009
How would I treat? EuroPCR 2009 20-05-2009
How would I treat? EuroPCR 2009 20-05-2009
Introduction EuroPCR 2009 21-05-2009
IVUS in bifurcation lesions and practical tips and tricks EuroPCR 2009 19-05-2009
Multivessel disease in the diabetic patient EuroPCR 2009 19-05-2009
The use of sirolimus-eluting cypher select stent in diabetic patients: a 6-month report from the e-select registry EuroPCR 2009 22-05-2009
DES in complex patient or lesion subsets EuroPCR 2008 14-05-2008
Case 1 - Discussion EuroPCR 2007 23-05-2007
Case 2 - Conclusion EuroPCR 2007 22-05-2007
Case 2 - Discussion EuroPCR 2007 23-05-2007
Case 3 - Discussion EuroPCR 2007 23-05-2007
Crossing side branches EuroPCR 2007 22-05-2007
Diffuse disease EuroPCR 2007 22-05-2007
Discussion EuroPCR 2007 23-05-2007
Identifying patients at high risk of chronic kidney disease EuroPCR 2007 23-05-2007
Importance of thrombo-resistance for the development of coronary drug-eluting stents EuroPCR 2007 24-05-2007
Introduction and learning objectives EuroPCR 2007 23-05-2007
Introduction and learning objectives EuroPCR 2007 23-05-2007
Take-home message EuroPCR 2007 23-05-2007
Take-home message EuroPCR 2007 23-05-2007
Do we need to dilate if infarct related artery is TIMI III? EuroPCR 2006 16-05-2006
First evidence from the latest innovation in stent material and design, CHRONO EuroPCR 2006 18-05-2006
How to use a protection device? EuroPCR 2006 16-05-2006
Introduction and learning objectives EuroPCR 2006 17-05-2006
Safety profile of DES EuroPCR 2006 17-05-2006
Take-home message EuroPCR 2006 17-05-2006
The patient is close to cathlab(<60mn) your advice to EUT EuroPCR 2006 16-05-2006


A. Bartorelli's Lectures
The patient is close to cathlab(<60mn) your advice to EUT EuroPCR 2006
Do we need to dilate if infarct related artery is TIMI III? EuroPCR 2006
Safety profile of DES EuroPCR 2006
Take-home message EuroPCR 2006
First evidence from the latest innovation in stent material and design, CHRONO EuroPCR 2006
Diffuse disease EuroPCR 2007
Introduction and learning objectives EuroPCR 2007
Take-home message EuroPCR 2007
Introduction and learning objectives EuroPCR 2007
Identifying patients at high risk of chronic kidney disease EuroPCR 2007
Take-home message EuroPCR 2007
Importance of thrombo-resistance for the development of coronary drug-eluting stents EuroPCR 2007
DES in complex patient or lesion subsets EuroPCR 2008
IVUS in bifurcation lesions and practical tips and tricks EuroPCR 2009
Diabetes associated with significant renal failure EuroPCR 2009
Multivessel disease in the diabetic patient EuroPCR 2009
How would I treat? EuroPCR 2009
How would I treat? EuroPCR 2009
Introduction EuroPCR 2009
The use of sirolimus-eluting cypher select stent in diabetic patients: a 6-month report from the e-select registry EuroPCR 2009
Introduction EuroPCR 2009


Back